💥 Gate Square Event: #PostToWinPORTALS# 💥
Post original content on Gate Square related to PORTALS, the Alpha Trading Competition, the Airdrop Campaign, or Launchpool, and get a chance to share 1,300 PORTALS rewards!
📅 Event Period: Sept 18, 2025, 18:00 – Sept 25, 2025, 24:00 (UTC+8)
📌 Related Campaigns:
Alpha Trading Competition: Join for a chance to win rewards
👉 https://www.gate.com/announcements/article/47181
Airdrop Campaign: Claim your PORTALS airdrop
👉 https://www.gate.com/announcements/article/47168
Launchpool: Stake GT to earn PORTALS
👉 https://www.gate.com/announcements/articl
BIO (Bio Protocol) rose 6.18% in 24 hours
Gate News Bot message, September 19, according to CoinMarketCap data, as of the time of writing, BIO (Bio Protocol) is currently priced at 0.17 USD, up 6.18% in the last 24 hours, with a highest price of 0.19 USD and a lowest price of 0.15 USD. The 24-hour volume reached 143 million USD. The current market capitalization is approximately 290 million USD, an increase of 16.9 million USD compared to yesterday.
Bio Protocol is a new financial layer of DeSci (decentralized science) aimed at accelerating the commercialization of the best scientific achievements. The protocol allows anyone to fund, develop, and manage tokenized scientific innovations from universities, companies, and researchers around the world. The Bio ecosystem is driving biotechnology innovation by guiding funds and talent to the most promising early-stage scientific projects through decentralized financing and coordination.
Important news about BIO recently:
1️⃣ Completed $6.9 million financing and launched Bio V2 platform Bio Protocol announced the completion of a $6.9 million financing on September 17, led by Maelstrom Fund, with participation from well-known institutions such as Mechanism Capital and Animoca Brands. At the same time, it launched the Bio V2 platform, introducing on-chain fundraising, a decentralized AI research framework, and an incentive system called BioXP. This significant financing and platform upgrade inject new development momentum into the BIO project, promising to drive innovation and application in the field of decentralized science.
2️⃣ BioAgents collaboration has achieved significant results The decentralized scientific AI agent BioAgents launched by Bio Protocol has collaborated with VitaDAO and the Aubrey de Grey laboratory. Since its launch in August, BioAgents has generated over $250,000 in research funding and over 1,000 longevity hypotheses. This achievement demonstrates the practical effects of Bio Protocol in promoting research funding and scientific innovation, helping to enhance the market's recognition of its value.
3️⃣ IP Token is about to launch on Bio V2 Bio Protocol announces that the IP token will soon be launched on the Bio V2 platform and will be sold to BIO and BioXP holders through Ignition Sales. The IP token represents a single atomic unit of science, such as new compounds, screening systems, or treatment methods, which can be generated by BioAgents, BioDAOs, or individual laboratories. This initiative will introduce a new value circulation mechanism to the Bio ecosystem, potentially increasing the utility and demand for BIO tokens.
From a technical perspective, the recent rise of BIO may be related to these positive developments. The completion of financing, platform upgrades, and the introduction of new tokens have brought new development opportunities to the BIO project, potentially igniting market optimism. However, investors still need to closely monitor the project's long-term development and the overall market trend.
This message is not intended as investment advice; investors should be aware of market volatility risks.